Home > News > US-based CytImmune gears up to target cancer cure
June 18th, 2007
US-based CytImmune gears up to target cancer cure
We all know there is no magic bullet for cancer. But scientists across the world are working on novel projects like cancer vaccines and newer tools like nanotechnology to conquer cancer, reports CNBC-TV18.
CytImmune is a small US-based nanotechnology company, but it has set a big goal for itself. CytImmune scientists are developing a nanotechnology-based Drug Delivery System that can target cancerous tumours leaving healthy organs and tissues untouched.
Novel nanoparticles could save soldiers' lives after explosions April 15th, 2015
Nanoparticles at specific temperature stimulate antitumor response: Dartmouth researchers identify precise heat to boost immune system against cancer tumors April 14th, 2015
Iranian Scientists Evaluate Dynamic Interaction between 2 Carbon Nanotubes April 14th, 2015
Gold by special delivery intensifies cancer-killing radiation April 13th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
The National Science Foundation names engineering researcher Andrea Alú its Alan T. Waterman awardee for 2015: Alú is a pioneer in the field of metamaterials who has developed "cloaking" technology to make objects invisible to sensors April 16th, 2015
Major advance in artificial photosynthesis poses win/win for the environment: Berkeley Lab researchers perform solar-powered green chemistry with captured CO2 April 16th, 2015
Newly-Developed Nanocatalysts Increase Performance of Fuel Cells April 16th, 2015
Nanotubes with two walls have singular qualities: Rice University lab calculates unique electronic qualities of double-walled carbon nanotubes April 16th, 2015